Safety, tolerability, and efficacy of KP-1461 as monotherapy for 124 days in antiretroviral-experienced, HIV type 1-infected subjects

Charles Hicks, Patrick Clay, Robert Redfield, Jay Lalezari, Ralph Liporace, Stefan Schneider, Michael Sension, Mary Peace Mcrae, Jean Pierre Laurent

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint Dive into the research topics of 'Safety, tolerability, and efficacy of KP-1461 as monotherapy for 124 days in antiretroviral-experienced, HIV type 1-infected subjects'. Together they form a unique fingerprint.

Medicine & Life Sciences